Acquisition by Slattery Joseph P of 12012 shares of CVRx subject to Rule 16b-3
| CVRX Stock | USD 13.17 0.45 3.30% |
Slightly above 62% of CVRx's investor base is looking to short. The analysis of overall sentiment of trading CVRx Inc stock suggests that many investors are alarmed at this time. CVRx's investing sentiment can be driven by a variety of factors including economic data, CVRx's earnings reports, geopolitical events, and overall market trends.
CVRx |
Filed transaction by Cvrx Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
CVRx Fundamental Analysis
We analyze CVRx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CVRx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CVRx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
CVRx is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
CVRx Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CVRx stock to make a market-neutral strategy. Peer analysis of CVRx could also be used in its relative valuation, which is a method of valuing CVRx by comparing valuation metrics with similar companies.
Peers
CVRx Related Equities
| AXGN | Axogen | 0.42 |
| ||
| SRDX | SurModics | 0.58 |
| ||
| AXDX | Accelerate Diagnostics | 0.90 |
| ||
| LIVN | LivaNova PLC | 1.06 |
| ||
| SGHT | Sight Sciences | 1.11 |
| ||
| AORT | Artivion | 1.16 |
| ||
| OFIX | Orthofix Medical | 1.68 |
| ||
| ELMD | Electromed | 1.88 |
| ||
| KIDS | Orthopediatrics Corp | 2.10 |
| ||
| ANIK | Anika Therapeutics | 2.46 |
| ||
| LUNG | Pulmonx Corp | 2.62 |
| ||
| NPCE | Neuropace | 5.99 |
|
Additional Tools for CVRx Stock Analysis
When running CVRx's price analysis, check to measure CVRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVRx is operating at the current time. Most of CVRx's value examination focuses on studying past and present price action to predict the probability of CVRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVRx's price. Additionally, you may evaluate how the addition of CVRx to your portfolios can decrease your overall portfolio volatility.